Épisodes

  • DeepSeek, Tesco & AJ Bell: The Companies and Markets Show
    Jan 31 2025

    Our panel kick off the podcast with a rundown of the latest news from the AI world. Chinese-owned DeepSeek’s smarter and more sustainable design helped knock half a billion dollars from Nvidia’s (NVIDIA) market cap. The panel discuss what comes next for AI stocks and return-hungry investors.


    It’s then on to Michael Fahy to chat about this week’s main feature on Tesco (TSCO). Michael explores how the supermarket's position has changed over the past few years, the mistakes it has made along the way and what comes next.


    Last up Val Cipriani and Julian Hoffman discuss AJ Bell’s (AJB) recent trading update. Listen to find out how the Budget has impacted the investing platform and how investors should consider the stock moving forward.


    Timestamps

    1:17 DeepSeek

    13:01 Tesco

    28:04 AJ Bell


    Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial

    *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.


    Hosted on Acast. See acast.com/privacy for more information.

    Voir plus Voir moins
    38 min
  • Predicting the market, US banks & biotech: The Companies and Markets Show
    Jan 24 2025

    On the week Donald Trump retook the position of US president, a handful of banking stocks released strong results. Jemma Slingo joins host Dan Jones to explore what investors need to know about Trump’s potential impact, the differences between UK and US banks, and a broader outlook for the year.


    It’s then onto this week’s cover feature on creating five-year outlooks for markets. Alex Newman runs through his thinking behind the piece, the challenges that arise when predicting market moves, and his predictions for gold.


    Last up, Julian Hoffman talks weight-loss drugs. He and Dan discuss what investors can expect in the year ahead, why Novo Nordisk’s results were disappointing, and more.


    Timestamps

    1:11 US banks

    12:22 A five-year outlook

    24:58 Biotech


    Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial

    *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.


    Hosted on Acast. See acast.com/privacy for more information.

    Voir plus Voir moins
    36 min
  • ‘Trusts need to do better’: Boaz Weinstein of Saba Capital
    Jan 21 2025

    Dave Baxter and Dan Jones sit down with the founder of Saba Capital, Boaz Weinstein. Last month, Saba sent the investment trust space into disarray by announcing it wanted to unseat board members at seven underperforming trusts, and merge them or offer shareholders a way out.


    In the episode, Dave and Dan grill Boaz on how Saba’s plans would work, what happens if it doesn’t win the votes, his belief that investors will benefit and more.


    The deadlines for shareholders to vote on Saba’s proposals vary, but in many cases, they are due before the end of January: check with your platform for details.


    How to vote in Saba's big investment trust battle


    Timestamps

    1:45 Are we too preoccupied with discounts?

    5:04 Critiques of Saba

    6:53 The plan when the results are in

    10:05 Professional investors’ view

    12:21 If they don’t win the votes

    15:01 Cash exits for trusts

    16:53 Trusts’ unlisted holdings eg. SpaceX

    19:57 The strategy for a new super-entity

    23:31 Where Saba’s attention will turn next

    25:55 If they win the vote, will they mimic US processes?

    28:10 Can Saba keep discounts in check?


    Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial

    *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.



    Hosted on Acast. See acast.com/privacy for more information.

    Voir plus Voir moins
    30 min
  • Small-cap income stocks & Games Workshop: The Companies and Markets Show
    Jan 16 2025

    This week’s episode starts off with a discussion of Games Workshop’s (GAW) results which showed strong core revenues. Valeria Martinez looks at how the business is performing geographically, the catalysts of its growth, its forecasts and more.


    Julian Hofmann then gives listeners an insight into our latest cover feature on dividend minnows. He shares the background of his research on the history of dividends in the FTSE 100 and highlights what investors should be wary of when it comes to large-cap dividends. He also touches on some examples from the piece such as brickmaker, Brickabilty (BRCK).


    Last up is the pig and cattle genetics company Genus (GNS). Shares were up 20 per cent in just one day earlier in the week, a change of tune from its performance in previous years. Julian touches on the backdrop for the company’s performance and why it’s hard to price.


    Timestamps

    1:09 Games Workshop

    17:00 Income minnows

    25:34 Genus


    Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial

    *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.


    Hosted on Acast. See acast.com/privacy for more information.

    Voir plus Voir moins
    35 min
  • ‘I’m optimistic about stocks in 2025’: Lee and the IC
    Jan 14 2025

    The duo reunite after the festive period for a conversation on how Lord Lee’s portfolio performed, why he feels optimistic about the next 12 months and how he’s invested a strong flow of dividends.


    The pair discuss Christie Group plc, a stock Lord Lee suggests is “severely underrated”, his opinion on what to do with a company that’s down 50 per cent, and British big-names ITV, Aviva and Supermarket Income Reit.


    The episode rounds up in the typical style, updating listeners on new holdings or recent exits in Lord Lee’s portfolio.


    If you have any questions you would like answered in the podcast, please send them to alex.newman@ft.com


    Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial

    *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.


    Timestamps

    1:14 Optimism about the year ahead

    3:48 2024 review

    5:20 Reinvesting dividends

    6:55 Christie Group plc

    10:54 What he would do at a 50 per cent loss

    13:41 Should companies consult investors

    15:38 Aviva and Direct Line

    19:39 ITV

    21:30 Supermarket Income Reit

    27:18 New positions and recent exits




    Hosted on Acast. See acast.com/privacy for more information.

    Voir plus Voir moins
    32 min
  • Yields, risk management and retailers: The Companies and Markets Show
    Jan 13 2025

    We begin with trading updates from retailers and update investors on all they need to know about Next (NXT), M&S (MKS) and Greggs (GRG). There is considerable pressure across the board due to higher national insurance contributions, rising wages and uncertain consumer sentiment. Michael Fahy, Mark Robinson and Alex Newman weigh in.


    Mark Robinson talks all things risk management, the topic of our latest Big Read. Mark touches on the golden rules to follow, how to protect a portfolio and more.


    Next up is bond yields, a hot topic given the market turmoil, and the team discuss what’s happening and whether bonds can still be considered a diversifier away from stocks.


    Timestamps

    1:21 Retailers

    18:02 Risk management


    Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial

    *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.




    Hosted on Acast. See acast.com/privacy for more information.

    Voir plus Voir moins
    35 min
  • Activist investing, Hollywood Bowl & US markets: The Companies and Markets Show
    Dec 20 2024

    We begin the year's final podcast discussing activist investor Saba Capital. Funds editor Dave Baxter explores the impact of its demand to remove the boards of seven investment trusts and what investors should do if the changes go ahead.


    It’s then onto Hollywood Bowl’s (BOWL) results. The company reported a 7 per cent rise in revenue, but shares still fell 10 per cent. Michael Fahy explains what caused the fall as well as the business's valuation.


    Last up, our US-based writer Arthur Sants joins in the studio. From the recent market sell-off after comments from the Fed to the Magnificent Seven stocks, investors can find out what to expect from American markets in the coming year.


    Timestamps

    1:17 Saba Capital

    9:31 Hollywood Bowl

    17:43 The US


    Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial

    *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.


    Hosted on Acast. See acast.com/privacy for more information.

    Voir plus Voir moins
    29 min
  • Small-cap expert Simon Thompson’s 2024 review: IC Interviews
    Dec 17 2024

    After a busy year of geopolitical changes, there is a lot of ground to cover when discussing markets. In this episode, Simon and Dan Jones unpack everything from the mass number of moves to the US market to knotty Aim shares, and the sectors investors should keep an eye on in 2025.


    Timestamps

    01:02 2025 prospects

    06:06 Economic backdrop

    10:23 Upgrades and downgrades

    15:31 Donald Trump’s presidency

    21:12 His take on moves to US markets

    24:16 Buybacks

    29:20 Aim

    32:16 IPOs and M&A

    33:59 Interesting sectors


    Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit www.investorschronicle.co.uk/podcasttrial

    *After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.




    Hosted on Acast. See acast.com/privacy for more information.

    Voir plus Voir moins
    37 min